Announcements Trials

Browse Landscape

Phase

Phase 2 58 Phase 1 23 Phase 3 11 Phase 1/2 9 Phase NA 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 1

Interventions

Cisplatin 30 Magnetic Resonance Spectroscopy 23 Carboplatin 23 pembrolizumab 21 Paclitaxel 20 Gemcitabine 19 Specimen Handling 16 Dexamethasone 15 Radiotherapy 14 Nivolumab 14 Drug Therapy 14 Doxorubicin 14 Bevacizumab 14 atezolizumab 13 Oxaliplatin 13 Cyclophosphamide 13 Radiation 11 Pemetrexed 11 Cytarabine 11 venetoclax 10 Vincristine 10 Prednisone 10 Docetaxel 10 Capecitabine 10 Trastuzumab 9 Temozolomide 8 Rituximab 8 Platinum 8 Ipilimumab 8 Fluorouracil 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Melphalan × 1 year × Clear all

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡